International Patent: A TUMOR-SPECIFIC HLA-BOUND NEOANTIGENIC PEPTIDE ENCODED BY EWSR1::FLI1-INDUCED NEOGENES

GENEVA, July 27 -- INSTITUT CURIE filed a patent application (EP2026/051063) for “A TUMOR-SPECIFIC HLA-BOUND NEOANTIGENIC PEPTIDE ENCODED BY EWSR1::FLI1-INDUCED NEOGENES”. With publication no. WO/2026/154125, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: A61K 40/11

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....